{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T09:21:18Z","timestamp":1794648078400,"version":"4.9.1"},"reference-count":38,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T00:00:00Z","timestamp":1779235200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Osteosarcoma (OS) is characterized by significant intratumoral heterogeneity and a remodeled immune microenvironment. However, the mechanisms through which metabolic reprogramming drives tumor progression are not fully understood. Lactylation, an epigenetic modification derived from lactate, has recently emerged as a key regulator of tumor metabolism and immune modulation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We employed an integrative multi-omics approach, combining single-cell RNA sequencing, spatial transcriptomics, and machine learning-based prognostic modeling to decipher lactylation-associated networks in OS. Key drivers were identified through co-expression network analysis and SHapley Additive exPlanations (SHAP) interpretability frameworks, followed by experimental functional validation and virtual screening for potential therapeutics.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      We identified a distinct tumor subpopulation exhibiting high lactylation activity, genomic instability, and stem-like properties, which is associated with unfavorable patient prognosis. Network and SHAP analyses pinpointed hepatoma-derived growth factor (HDGF) as a central regulator within this axis. Functional studies demonstrated that HDGF knockdown potently inhibited OS cell proliferation, migration, invasion, and tumor growth\n                      <jats:italic>in vivo<\/jats:italic>\n                      . Spatial transcriptomics confirmed the colocalization of elevated lactylation activity and HDGF expression within tumor regions, linking metabolic reprogramming to the local microenvironment. Furthermore, virtual screening identified several FDA-approved compounds with high predicted binding affinity for HDGF.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Our study unveils a novel lactylation\u2013HDGF regulatory association that promotes OS progression and modulates the tumor microenvironment. These findings highlight HDGF as a promising prognostic biomarker and therapeutic target, offering new avenues for precision therapy in osteosarcoma.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1836254","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T05:38:56Z","timestamp":1779255536000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["Lactylation-driven metabolic reprogramming promotes osteosarcoma malignancy via HDGF-mediated proliferation and immune modulation"],"prefix":"10.3389","volume":"17","author":[{"given":"Shidong","family":"Hu","sequence":"first","affiliation":[{"name":"Department of Spine Surgery, Zhongda Hospital Southeast University","place":["Nanjing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Orthopedic Surgery, The Second Affiliated Hospital of Chongqing Medical University","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianhua","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Oncology, The First Affiliated Hospital of Dali University","place":["Dali, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengsheng","family":"Dai","sequence":"additional","affiliation":[{"name":"Chongqing Key Laboratory for the Mechanism and Intervention of Cancer Metastasis, Chongqing University Cancer Hospital, Chongqing University","place":["Chongqing, China"]},{"name":"Department of Hepatobiliary Pancreatic Tumor Center, Chongqing University Cancer Hospital","place":["Chongqing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,20]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3390\/cells9040976","article-title":"The osteosarcoma microenvironment: A complex but targetable ecosystem","volume":"9","author":"Corre","year":"2020","journal-title":"Cells"},{"key":"B2","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1186\/s13045-024-01598-7","article-title":"A single-cell and spatially resolved atlas of human osteosarcomas","volume":"17","author":"Zheng","year":"2024","journal-title":"J Hematol Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2023.154881","article-title":"Baicalin induces ferroptosis in osteosarcomas through a novel Nrf2\/xCT\/GPX4 regulatory axis","volume":"116","author":"Wen","year":"2023","journal-title":"Phytomedicine"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(22)01790-1","article-title":"Comparison of two chemotherapy regimens in patients with newly diagnosed Ewing sarcoma (EE2012): An open-label, randomized, phase 3 trial","volume":"400","author":"Brennan","year":"2022","journal-title":"Lancet"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.phymed.2024.156139","article-title":"Shikonin induces ferroptosis in osteosarcomas through the mitochondrial ROS-regulated HIF-1\u03b1\/HO-1 axis","volume":"135","author":"Lu","year":"2024","journal-title":"Phytomedicine"},{"key":"B6","doi-asserted-by":"publisher","first-page":"928","DOI":"10.1038\/s41419-024-07264-7","article-title":"KDELR1 regulates chondrosarcoma drug resistance and Malignant behavior through Intergrin-Hippo-YAP1 axis","volume":"15","author":"Yin","year":"2024","journal-title":"Cell Death Dis"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1002\/jev2.70123","article-title":"NK-cell-derived extracellular vesicles engineered to carry senolytics eliminate chemotherapy-induced senescent osteosarcoma cells","volume":"14","author":"Yue","year":"2025","journal-title":"J Extracell Vesicles"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2025.02.011","article-title":"The role of protein lactylation: A kaleidoscopic post-translational modification in cancer","volume":"85","author":"Iozzo","year":"2025","journal-title":"Mol Cell"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1229397","article-title":"Advances in post-translational modifications of proteins and cancer immunotherapy","volume":"14","author":"Li","year":"2023","journal-title":"Front Immunol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2024-010787","article-title":"Novel post-translational modification learning signature reveals B4GALT2 as an immune exclusion regulator in lung adenocarcinoma","volume":"13","author":"Zhang","year":"2025","journal-title":"J Immunother Cancer"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2024.09.006","article-title":"Lactylation in cancer: Current understanding and challenges","volume":"42","author":"Li","year":"2024","journal-title":"Cancer Cell"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jare.2025.06.020","article-title":"Targeting post-translational modifications: Novel insights into bone metabolic diseases","volume":"81","author":"Kong","year":"2026","journal-title":"J Adv Res"},{"key":"B13","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1007\/s10142-025-01559-4","article-title":"Integrative single-cell and bulk RNA-seq analysis identifies lactylation-related signature in osteosarcoma","volume":"25","author":"Xie","year":"2025","journal-title":"Funct Integr Genomics"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2019-319639","article-title":"METTL3-mediated m6A modification of HDGF mRNA promotes gastric cancer progression and has prognostic significance","volume":"69","author":"Wang","year":"2020","journal-title":"Gut"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.3390\/biom15020282","article-title":"HDGF knockout suppresses colorectal cancer progression and drug resistance by modulating the DNA damage response","volume":"15","author":"Su","year":"2025","journal-title":"Biomolecules"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.2217\/fon.14.194","article-title":"HDGF: A novel jack-of-all-trades in cancer","volume":"10","author":"Bao","year":"2014","journal-title":"Future Oncol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.prp.2019.152492","article-title":"Upregulation of miR-95-3p inhibits growth of osteosarcoma by targeting HDGF","volume":"215","author":"Liu","year":"2019","journal-title":"Pathol Res Pract"},{"key":"B18","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s13238-021-00846-7","article-title":"Metabolic reprogramming and epigenetic modifications on the path to cancer","volume":"13","author":"Sun","year":"2022","journal-title":"Protein Cell"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/ph16050644","article-title":"Lactylation-related gene signature effectively predicts prognosis and treatment responsiveness in hepatocellular carcinoma","volume":"16","author":"Cheng","year":"2023","journal-title":"Pharm (Basel)"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1002\/ctm2.1586","article-title":"Identifying squalene epoxidase as a metabolic vulnerability in high-risk osteosarcoma using an artificial intelligence-derived prognostic index","volume":"14","author":"Wang","year":"2024","journal-title":"Clin Transl Med"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2023.101106","article-title":"PDCD2 as a prognostic biomarker in glioma correlates with Malignant phenotype","volume":"11","author":"Dai","year":"2024","journal-title":"Genes Dis"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-019-0361-y","article-title":"5-methylcytosine promotes pathogenesis of bladder cancer through stabilizing mRNAs","volume":"21","author":"Chen","year":"2019","journal-title":"Nat Cell Biol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/cpr.13478","article-title":"Lactate-induced protein lactylation: A bridge between epigenetics and metabolic reprogramming in cancer","volume":"56","author":"Wang","year":"2023","journal-title":"Cell Prolif"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.2165\/00002018-200124030-00005","article-title":"Saquinavir soft gelatin capsule: A comparative safety review","volume":"24","author":"Gill","year":"2001","journal-title":"Drug Saf"},{"key":"B25","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1111\/head.13700","article-title":"Dihydroergotamine (DHE) - Then and now: A narrative review","volume":"60","author":"Silberstein","year":"2020","journal-title":"Headache"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1640645","article-title":"Deciphering spatially confined immune evasion niches in osteosarcoma with 3-D spatial transcriptomics: A literature review","volume":"15","author":"Qiu","year":"2025","journal-title":"Front Oncol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1155\/ancp\/6517238","article-title":"Decoding osteosarcoma's lactylation gene expression: Insights into prognosis, immune dynamics, and treatment","volume":"2025","author":"Peng","year":"2025","journal-title":"Anal Cell Pathol (Amst)"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/nature13490","article-title":"Functional polarization of tumor-associated macrophages by tumor-derived lactic acid","volume":"513","author":"Colegio","year":"2014","journal-title":"Nature"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-07-035972","article-title":"Inhibitory effect of tumor cell-derived lactic acid on human T cells","volume":"109","author":"Fischer","year":"2007","journal-title":"Blood"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1245\/ASO.2006.11.035","article-title":"Hepatoma-derived growth factor is a novel prognostic factor for hepatocellular carcinoma","volume":"13","author":"Yoshida","year":"2006","journal-title":"Ann Surg Oncol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1042\/CS20242737","article-title":"Insight into the roles of lactylation in macrophages: Functions and clinical implications","volume":"139","author":"Shu","year":"2025","journal-title":"Clin Sci (Lond)"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S91708","article-title":"The expression and clinical significance of HDGF in osteosarcoma","volume":"8","author":"Chen","year":"2015","journal-title":"Onco Targets Ther"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1038\/s42255-025-01259-0","article-title":"The emerging role of protein L-lactylation in metabolic regulation and cell signaling","volume":"7","author":"Ren","year":"2025","journal-title":"Nat Metab"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2014.12.001","article-title":"Hepatocarcinoma cell-derived hepatoma-derived growth factor (HDGF) induces regulatory T cells","volume":"72","author":"Sun","year":"2015","journal-title":"Cytokine"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1152\/ajplung.00427.2003","article-title":"Hepatoma-derived growth factor is a pulmonary endothelial cell-expressed angiogenic factor","volume":"286","author":"Everett","year":"2004","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1675480","article-title":"Lactylation as a cross-regulatory node in tumor metabolism and epigenetics: Insights and therapeutic implications","volume":"16","author":"Lv","year":"2025","journal-title":"Front Immunol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nrd.2018.168","article-title":"Drug repurposing: Progress, challenges and recommendations","volume":"18","author":"Pushpakom","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.59.4895","article-title":"Osteosarcoma: Current treatment and a collaborative pathway to success","volume":"33","author":"Isakoff","year":"2015","journal-title":"J Clin Oncol"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1836254\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T05:38:58Z","timestamp":1779255538000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1836254\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,20]]},"references-count":38,"alternative-id":["10.3389\/fimmu.2026.1836254"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1836254","relation":{"has-part":[{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2026.1836254.s001","asserted-by":"subject"},{"id-type":"doi","id":"https:\/\/doi.org\/10.3389\/fimmu.2026.1836254.s002","asserted-by":"subject"}]},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,20]]},"article-number":"1836254"}}